시장보고서
상품코드
1299748

에리스로포이에틴 제제 시장 : 유형별, 제품별, 용도별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2023-2030년)

Erythropoietin Drugs Market with COVID-19 Impact Analysis, By Type, By Product, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 358 Pages | 배송안내 : 2-3일 (영업일 기준)


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 주요 내용

에리스로포이에틴 제제 시장 규모는 2022년 70억 810만 달러로 2023년부터 2030년까지 CAGR 10.5%로 확대

에리스로포이에틴 제제 시장 - 시장 역학:

ESRD 치료, 항레트로바이러스 치료, 화학요법으로 인한 빈혈 상태의 유병률 증가는 에리스로포이에틴 시장 수요를 증가시킬 것으로 예상되는 주요 요인입니다. 또한, 빈혈 치료 외에도 유전자 재조합 인간 에리스로포이에틴은 뇌 손상과 같은 몇 가지 치료적 이점이 있습니다. 또한, 에리스로포이에틴을 전신 투여하면 혈액뇌장벽을 통과하기 때문에 신경가소성을 개선하고 많은 뇌질환에서 인지기능을 향상시킬 수 있습니다. 그러나 에리스로포이에틴 제제의 비용 상승은 예측 기간 동안 시장 성장을 억제하는 주요 요인 중 하나입니다.

또한, 에리스로포이에틴 제제의 장점에 대한 인식이 높아지고, 쉽게 이용할 수 있는 상환, 에리스로포이에틴 제제 바이오시밀러의 상업화 추세는 EPO 치료제 시장의 성장을 촉진할 것으로 예상됩니다. COVID-19 팬데믹은 에리스로포이에틴 제제 시장에 긍정적인 영향을 미쳤습니다. 의약품에 대한 수요가 증가하고 다양한 의료 서비스에 대한 수요도 증가했습니다. 또한, 이 의약품은 빈혈 치료에 도움이 되며 COVID-19에도 효과가 있는 것으로 알려져 있습니다.

에리스로포이에틴 제제 시장 - 세분화 분석:

세계 에리스로포이에틴 제제 시장은 유형, 제품, 용도 및 지역별로 분류됩니다.

바이오의약품과 바이오시밀러 두 가지로 나뉩니다. 바이오시밀러 분야가 시장을 독점할 가능성이 높습니다. 강력한 제품 파이프라인, 제조업체와 병원 간의 파트너십 증가, 개발 연구 자금의 증가 등이 그 이유입니다.

시장은 제품별로 에리스로포이에틴과 다베포에틴-알파의 두 가지로 나뉩니다. 다베포에틴-알파 제제가 시장을 점유할 것으로 예상됩니다. 이는 부분적으로 다베포에틴-알파가 암 화학요법을 받은 환자에게 발생하는 빈혈을 치료하는 데 도움이 되기 때문입니다.

시장 규모는 용도별로 암, 신장 질환, 신경 및 기타 세 가지 범주로 나뉩니다. 예측 기간 동안 가장 큰 시장 점유율을 차지하는 것은 암 분야로 추정됩니다. 알코올, 서유럽식 생활습관, 흡연, 식습관 장애로 인해 암 환자가 증가하고 있습니다. 이는 암 분야의 성장을 촉진할 것입니다.

에리스로포이에틴 제제 시장 - 경쟁 상황:

에리스로포이에틴 제제에 대한 수요 증가는 세계 시장 성장을 촉진할 것입니다. 또한, 시장 참여자들은 신제품 출시, 파트너십, 합작 투자, 제휴 및 지역적 성장에 주력하고 있습니다. 또한, 암 환자의 빈혈이 증가함에 따라 에리스로포이에틴 제제 시장의 성장을 촉진하고 있습니다. 또한, 시장 기업이 사업을 강화하고 확장하기 위해 사용하는 전략에는 R&D 비용, 인수합병(M&A), 판로 개척 등이 포함됩니다. 예를 들어, 2022년 3월 Zydus Lifesciences는 Oxemia(Desidustat)의 신약 승인을 획득했습니다. 또한, 만성신장질환(CKD)에 따른 빈혈에 대한 최초의 경구용 치료제로서 인도 의약품감독청(DCGI)의 승인을 받았습니다.

연구의 주요 특징

이 보고서는 에리스로포이에틴 제제 시장의 시장 규모, CAGR, 2022년을 기준 연도로 한 추정 및 예측(2023-2030년)을 제공합니다.

이 조사 보고서는 다양한 부문/국가에 걸쳐 잠재적인 성장 기회를 파악하고 에리스로포이에틴 제제 시장의 매력적인 투자 제안 매트릭스를 설명합니다.

이 보고서는 전체 보고서에서 신규 투자 기회, 기존 기업이 직면한 과제, 에리스로포이에틴 제제 시장에서 지속가능한 성장 요인을 확인했습니다.

COVID-19가 에리스로포이에틴 제제의 시장 규모, 예측, CAGR 및 시장 역학에 미치는 영향은 연구 범위에서 자세히 논의되며, 코로나 이후 에리스로포이에틴 제제 시장에 대한 심층적인 인사이트도 다루고 있습니다.

이 보고서는 사용자에게 에리스로포이에틴 제제 시장에 대한 종합적인 관점을 제공하기 위해 에리스로포이에틴 제제 시장의 경쟁 상황과 주요 혁신가 분석도 포함하고 있습니다.

이 연구는 시장 규모, 성장률, 매력도를 기준으로 모든 산업 부문을 벤치마킹하는 성장 전망 매핑 분석을 포함하고 있습니다.

이 보고서는 주요 시장 참여자를 다루는 상세한 회사 프로필을 제공하여 에리스로포이에틴 제제 시장에서 사업을 운영하는 기업의 재무 정보 및 전략적 이니셔티브를 이해하는 데 도움이 됩니다.

또한 이 보고서는 세계 및 지역 차원에서 시장에 참여하는 주요 참가자들의 주요 인수합병, 협업 및 합작투자, 신규 출시, R&D, 지역 확장 등 주요 인수 및 합병을 확인할 수 있습니다.

에리스로포이에틴 제제 세계 시장 보고서는 주로 공급 업체, 투자자, 신규 진입자, 유통 업체, 금융 분석가 등 이 산업의 다양한 이해 관계자를 대상으로 합니다.

목차

제1장 에리스로포이에틴 제제 시장 개요

  • 조사 범위

제2장 주요 요약

  • 시장 내역
  • 경쟁 인사이트

제3장 에리스로포이에틴 제제 주요 시장 동향

  • 에리스로포이에틴 제제 시장 성장 촉진요인
  • 에리스로포이에틴 제제 시장 성장 억제요인
  • 에리스로포이에틴 제제 시장 기회
  • 에리스로포이에틴 제제 시장 전망 동향

제4장 에리스로포이에틴 제제 산업 조사

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 매핑
  • 규제 체계 분석

제5장 에리스로포이에틴 제제 시장 : COVID-19의 영향 분석

  • COVID-19 이전의 영향 분석
  • COVID-19 이후의 영향 분석

제6장 에리스로포이에틴 제제 시장 상황

  • 에리스로포이에틴 제제 시장 점유율 분석, 2022년
  • 주요 제조업체별 내역 데이터
    • 기존 기업 분석
    • 신흥 기업 분석

제7장 에리스로포이에틴 제제 시장 - 유형별

  • 개요
    • 유형별 부문 점유율 분석
    • 생물제제
    • 바이오시밀러

제8장 에리스로포이에틴 제제 시장 - 제품별

  • 개요
    • 제품별 부문 점유율 분석
    • 에리스로포이에틴
    • 다베포에틴 알파

제9장 에리스로포이에틴 제제 시장 - 용도별

  • 개요
    • 용도별 부문 점유율 분석
    • 신장병
    • 신경내과
    • 기타

제10장 에리스로포이에틴 제제 시장 - 지역별

  • 서론
  • 북미
    • 개요
    • 북미의 에리스로포이에틴 제제 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 에리스로포이에틴 제제 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양의 에리스로포이에틴 제제 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카의 에리스로포이에틴 제제 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 에리스로포이에틴 제제 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제11장 주요 벤더 분석 - 에리스로포이에틴 제제 산업

  • 경쟁 대시보드
  • 기업 개요
    • AstraZeneca(UK)
    • Lupin(India)
    • Bristol-Myers Squibb Company(US)
    • Endo International plc(Ireland)
    • JCR Pharmaceuticals Co., Ltd(Japan)
    • Pfizer Inc(US)
    • Teva Pharmaceutical Industries Ltd(Israel)
    • Sun Pharmaceutical Industries Ltd(India)
    • Dr. Reddy's Laboratories Ltd(India)
    • Mylan NV(US)
    • Novartis AG(Switzerland)
    • Cipla Inc(India)
    • Shanghai Dahua Pharmaceutical Co., Ltd(China)

제12장 애널리스트의 전방위적 전망

ksm 23.08.16

REPORT HIGHLIGHT

Erythropoietin drugs market size was valued at USD 7,008.1 Million in 2022, expanding at a CAGR of 10.5% from 2023 to 2030.

Erythropoietin (EPO) is also known as hematopoietin, a glycoprotein hormone secreted from the kidneys that play an important role in the development of red blood cells (RBCs) in the bone by stimulating the bone marrow tissues. Additionally, a rise in RBC count increases the hemoglobin level in the bloodstream and delivers a sufficient amount of oxygen to every part of the body. Moreover, erythropoietin medications are largely used in the treatment of anemia caused by end-stage renal disease (ESRD) and dialysis procedures.

Erythropoietin Drugs Market- Market Dynamics:

The increasing prevalence of anemic conditions caused by ESRD treatment, antiretroviral treatment, and chemotherapy are major factors projected to increase the demand for the erythropoietin market. Additionally, besides treating anemia, several therapeutic advantages are associated with recombinant human erythropoietin such as brain disorders. Moreover, if erythropoietin is administered systematically, it passes the blood-brain barrier as a result improving neuroplasticity and rising cognitive functions in many brain disorders. However, the increasing cost of erythropoietin drugs is one of the major factors that could restrain the market growth during the forecast period.

Furthermore, increasing awareness regarding the advantages of erythropoietin therapeutics drugs, readily available reimbursements, and rising trends of commercialization for erythropoietin biosimilars are expected to boost the EPO drugs market growth. The COVID-19 pandemic had a positive impact on the erythropoietin drugs market. It increased the demand for medicines and also increased the demand for various medical services. Additionally, the drug is helpful in anemia treatment and works against COVID-19.

Erythropoietin Drugs Market- Segmentation Analysis:

The global erythropoietin drugs market is segmented on the basis of type, product, application, and region.

The market is divided into two categories based on type: biologics and biosimilars. The biosimilars sector is likely to dominate the market. Due to the strong product pipeline, an increasing partnership among manufacturers & hospitals, and rising funds for development & research.

The market is divided into two categories based on product: erythropoietin and darbepoetin-alfa. The darbepoetin-alfa sector is expected to possess the market. This is partially due to darbepoetin-alfa helping in treating anemia that occurs in a patient who received chemotherapy for cancer.

The market is divided into three categories based on application: cancer, renal diseases, neurology, and others. The cancer sector is estimated to hold the largest market share during the forecast period. Cancer cases are increasing due to the adoption of alcohol, western lifestyle, smoking, and poor diet choice. Thus in turn propel the cancer segment growth.

Erythropoietin Drugs Market-Competitive Landscape:

The increasing demand for erythropoietin drugs thus increases the market growth globally. Additionally, market players are focusing on new product launches, partnerships, joint ventures, collaborations, and regional growth. Moreover, an increase in anemia in cancer patients boosted the erythropoietin drug market growth. Furthermore, strategies used by market players to strengthen and expand their business include R&D spending, mergers & acquisitions, and distribution channel development. For instance, in March 2022, Zydus Lifesciences a company received the new drug approval for Oxemia (Desidustat). Additionally, it is a first-of-its-kind oral treatment for anemia associated with chronic kidney disease(CKD), from the Drugs Controller General of India (DCGI).

Key features of the study:

This proposed research study on erythropoietin drugs market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year

The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for erythropoietin drugs market.

The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the erythropoietin drugs market.

Impact of COVID-19 on erythropoietin drugs market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on erythropoietin drugs market post-COVID will also be covered.

In order to give the users of this report a comprehensive view on the erythropoietin drugs market, we have also included competitive landscape and key innovator analysis for the Erythropoietin Drugs Market.

The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.

The report offersdetailed company profiling featuring major market participantswhich will help users to understand their financial information and strategic initiatives of players operating in the erythropoietin drugs market.

In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.

The global erythropoietin drugs market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ERYTHROPOIETIN DRUGS MARKET KEY PLAYERS

  • AstraZeneca (U.K.)
  • Lupin (India)
  • Bristol-Myers Squibb Company (U.S.)
  • Endo International plc (Ireland)
  • JCR Pharmaceuticals Co., Ltd (Japan)
  • Pfizer Inc (U.S.)
  • Teva Pharmaceutical Industries Ltd (Israel)
  • Sun Pharmaceutical Industries Ltd (India)
  • Dr. Reddy's Laboratories Ltd (India)
  • Mylan N.V. (U.S.)
  • Novartis AG (Switzerland)
  • Cipla Inc (India)
  • Shanghai Dahua Pharmaceutical Co., Ltd (China)

GLOBALERYTHROPOIETIN DRUGS MARKET, BY TYPE

  • Biologics
  • Biosimilars

GLOBAL ERYTHROPOIETIN DRUGS MARKET, BY PRODUCT

  • Erythropoietin
  • Darbepoetin-alfa

GLOBAL ERYTHROPOIETIN DRUGS MARKET, BY APPLICATION

  • Cancer
  • Renal Diseases
  • Neurology
  • Others

GLOBAL ERYTHROPOIETIN DRUGS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Erythropoietin Drugs Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Erythropoietin Drugs Market Snippet by Type
    • 2.1.2. Erythropoietin Drugs Market Snippet by Product
    • 2.1.3. Erythropoietin Drugs Market Snippet by Application
    • 2.1.4. Erythropoietin Drugs Market Snippet by Country
    • 2.1.5. Erythropoietin Drugs Market Snippet by Region
  • 2.2. Competitive Insights

3. Erythropoietin Drugs Key Market Trends

  • 3.1. Erythropoietin Drugs Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Erythropoietin Drugs Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Erythropoietin Drugs Market Opportunities
  • 3.4. Erythropoietin Drugs Market Future Trends

4. Erythropoietin Drugs Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Erythropoietin Drugs Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Erythropoietin Drugs Market Landscape

  • 6.1. Erythropoietin Drugs Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Erythropoietin Drugs Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2022&2030 (%)
    • 7.1.2. Biologics
    • 7.1.3. Biosimilars

8. Erythropoietin Drugs Market - By Product

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Product, 2022&2030 (%)
    • 8.1.2. Erythropoietin
    • 8.1.3. Darbepoetin-alfa

9. Erythropoietin Drugs Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2022&2030 (%)
    • 9.1.2. Cancer
    • 9.1.3. Renal Diseases
    • 9.1.4. Neurology
    • 9.1.5. Others

10. Erythropoietin Drugs Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Erythropoietin Drugs Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Erythropoietin Drugs Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Erythropoietin Drugs Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Erythropoietin Drugs Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Erythropoietin Drugs Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Erythropoietin Drugs Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. AstraZeneca (U.K.)
    • 11.2.2. Lupin (India)
    • 11.2.3. Bristol-Myers Squibb Company (U.S.)
    • 11.2.4. Endo International plc (Ireland)
    • 11.2.5. JCR Pharmaceuticals Co., Ltd (Japan)
    • 11.2.6. Pfizer Inc (U.S.)
    • 11.2.7. Teva Pharmaceutical Industries Ltd (Israel)
    • 11.2.8. Sun Pharmaceutical Industries Ltd (India)
    • 11.2.9. Dr. Reddy's Laboratories Ltd (India)
    • 11.2.10. Mylan N.V. (U.S.)
    • 11.2.11. Novartis AG (Switzerland)
    • 11.2.12. Cipla Inc (India)
    • 11.2.13. Shanghai Dahua Pharmaceutical Co., Ltd (China)

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제